Schroders Capital Overview
- Year Founded
-
1997

- Status
-
Acquired/Merged
- Employees
-
500

- Latest Deal Type
-
M&A
- Financing Rounds
-
1
- Investments
-
92
Schroders Capital General Information
Description
Provider of asset management services intended to offer specialized investment services. The company's asset management services include private equity investment management, fund investment, specialized strategies and segments within private equity, such as small and mid-sized buyouts, early stage venture capital, growth capital and turnarounds, enabling clients such as venture capital, buyouts, co-investments, pension funds, insurance companies, endowments, family offices and other financial institutions to access select private market segments through primary, secondary and direct or co-investments.
Contact Information
- 1 London Wall Place
- London EC2Y 5AU
- England, United Kingdom
Schroders Capital Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Schroders Capital Comparisons
Industry
Financing
Details
Schroders Capital Competitors (9)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Pantheon. | Formerly PE-Backed | London, United Kingdom | 000 | 000000 - 000 | ||
000000000 | Corporation | New York, NY | 00000 | 000.00 | 000000000 00 | 000.00 |
00000000 0000 | Corporate Backed or Acquired | Philadelphia, PA | 000 | 00000 | 00000000 | 00000 |
000000000 000000 | Formerly PE-Backed | New York, NY | 0000 | 00000 | 000000000 00 | 00000 |
000000 00000000000 | Pending Transaction (M&A) | Kansas City, MO | 0000 | 000000&0 |
Schroders Capital Executive Team (90)
Schroders Capital Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
00000 0000000 | Schroders Capital | Founder & Non-executive Vice Chairman | 000 0000 |
0000 0000 00.0 | Schroders Capital | Chief Investment Officer and Member of the Investment Committee | 000 0000 |
Schroders Capital Signals
Schroders Capital Investments (92)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Memo Therapeutics | 02-Nov-2023 | 00000 0000 | 000.00 | Drug Discovery | |
Saber Power Services | 31-Oct-2023 | 0000000000 | Other Commercial Services | ||
Bizongo | 04-Oct-2023 | 00000 0000 | 0000 | Business/Productivity Software | |
Lenskart | 16-Jun-2023 | 00000 0000 | 00000 | Specialty Retail | |
Cohere | 02-Jun-2023 | Later Stage VC | 00000 | Software Development Applications |
Schroders Capital Exits (27)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Eikon Therapeutics | 06-Jan-2022 | 00000 00000 00 | 00000 | Completed |
|
Ambys Medicines | 21-Dec-2021 | 00000 00000 00 | 0000 | Completed |
|
Cedilla Therapeutics | 25-Oct-2021 | 00000 00000 00 | 000.00 | Completed |
|
LEAP India | 03-Aug-2021 | 000000000 00000000 | 0000 | Completed |
|
Mission Therapeutics | 06-Jul-2020 | Later Stage VC | 000.00 | Completed |
|